关于减肥药的任何风吹草动,都能在资本市场掀起狂风巨浪。2月20日港股开盘,歌礼制药-B(01672.HK)高开高走,盘中一度涨超36%,收盘报于6.44港元,涨34.45%。正式宣布进军肥胖药物领域5个月后,歌礼制药在2月19日港股盘后发布公告称,旗下用于治疗肥胖症的小分子GLP-1受体(GLP-1R)激动剂ASC30,美国Ib期多剂量递增研究前两个队列取得了积极期中结果。据了解,由歌礼自主研发的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.